Kerala Ayurveda Ltd. | Small-cap | Healthcare
₹494.05
-2.05%
| Kerala Ayurveda Stock Comparison:
Kerala Ayurveda vs Sun PharmaceuticalKerala Ayurveda vs Divi's LaboratoriesKerala Ayurveda vs Sun Pharma AdvancedKerala Ayurveda vs Aarti DrugsKerala Ayurveda vs Sequent ScientificKerala Ayurveda vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 286.1M
Gross Profit 216.4M 75.65%
Operating Income -58.4M -20.40%
Net Income 20.3M 7.09%
EPS (Diluted) ₹1.89

Balance Sheet Metrics

Total Assets 1.3B
Total Liabilities 1.2B
Shareholders Equity 128.9M
Debt to Equity 8.99

Cash Flow Metrics

Revenue & Profitability Trend

Kerala Ayurveda Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.2B1.1B930.5M800.0M618.7M
Cost of Goods Sold i226.9M224.3M203.8M175.3M153.3M
Gross Profit i976.4M850.1M726.7M624.7M465.4M
Gross Margin % i81.1%79.1%78.1%78.1%75.2%
Operating Expenses
Research & Development i-7.6M3.6M1.2M750.0K
Selling, General & Administrative i-176.5M168.9M122.0M94.7M
Other Operating Expenses i483.6M196.9M175.6M138.8M68.1M
Total Operating Expenses i483.6M380.9M348.1M261.9M163.6M
Operating Income i-99.7M71.3M50.1M98.6M43.7M
Operating Margin % i-8.3%6.6%5.4%12.3%7.1%
Non-Operating Items
Interest Income i-1.6M768.0K2.6M346.0K
Interest Expense i40.9M44.6M48.2M65.2M63.2M
Other Non-Operating Income-----
Pre-tax Income i-122.4M12.7M-5.6M28.0M-67.4M
Income Tax i17.2M21.3M-1.3M4.1M-18.9M
Effective Tax Rate % i0.0%167.9%0.0%14.7%0.0%
Net Income i-139.6M-8.6M-4.3M23.9M-48.4M
Net Margin % i-11.6%-0.8%-0.5%3.0%-7.8%
Key Metrics
EBITDA i-31.7M70.8M25.4M97.3M8.6M
EPS (Basic) i₹-12.79₹-1.38₹-0.85₹2.24₹-4.57
EPS (Diluted) i₹-12.79₹-1.38₹-0.85₹2.24₹-4.57
Basic Shares Outstanding i1149265111036000105560001055600010600000
Diluted Shares Outstanding i1149265111036000105560001055600010600000

Income Statement Trend

Kerala Ayurveda Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i33.9M227.9M43.8M28.7M185.6M
Short-term Investments i2.0M----
Accounts Receivable i193.0M158.0M129.6M133.4M103.3M
Inventory i129.6M155.0M124.9M119.7M110.0M
Other Current Assets48.2M-54.2M1.0K-1
Total Current Assets i407.7M600.9M352.5M371.5M436.5M
Non-Current Assets
Property, Plant & Equipment i310.5M239.0M9.1M9.6M9.6M
Goodwill i232.4M325.7M326.9M326.5M211.6M
Intangible Assets i82.7M120.5M121.8M121.3M6.4M
Long-term Investments-----
Other Non-Current Assets47.0K22.5M28.7M30.2M31.6M
Total Non-Current Assets i879.9M806.2M806.5M731.7M708.3M
Total Assets i1.3B1.4B1.2B1.1B1.1B
Liabilities
Current Liabilities
Accounts Payable i57.9M77.7M75.0M79.0M61.3M
Short-term Debt i484.4M101.7M238.6M327.3M189.8M
Current Portion of Long-term Debt-----
Other Current Liabilities256.1M8.3M7.1M21.9M21.4M
Total Current Liabilities i879.8M404.0M526.9M603.6M419.2M
Non-Current Liabilities
Long-term Debt i222.2M594.2M504.2M372.1M585.0M
Deferred Tax Liabilities i-1.8M000
Other Non-Current Liabilities-5.7M3.4M2.4M3.4M
Total Non-Current Liabilities i279.0M651.7M553.3M420.1M673.6M
Total Liabilities i1.2B1.1B1.1B1.0B1.1B
Equity
Common Stock i120.3M120.3M105.6M105.6M105.6M
Retained Earnings i--186.3M-170.7M-165.3M-192.4M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i128.9M351.3M78.8M79.4M52.0M
Key Metrics
Total Debt i706.6M695.8M742.8M699.4M774.8M
Working Capital i-472.1M196.8M-174.4M-232.2M17.3M

Balance Sheet Composition

Kerala Ayurveda Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-122.4M57.4M42.6M93.2M-4.2M
Depreciation & Amortization i-----
Stock-Based Compensation i62.3M----
Working Capital Changes i63.0M-47.9M39.5M-130.5M73.0M
Operating Cash Flow i43.7M7.8M81.4M-39.8M68.5M
Investing Activities
Capital Expenditures i-133.2M-10.8M-61.1M-28.5M-10.4M
Acquisitions i-----
Investment Purchases i-----
Investment Sales i----1.0M
Investing Cash Flow i-133.2M-10.8M-61.1M-28.5M-9.4M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-90.0M132.1M-136.4M
Debt Repayment i----213.0M-11.2M
Financing Cash Flow i29.1M221.0M36.9M-67.5M114.1M
Free Cash Flow i-85.0M9.2M36.8M-33.5M63.9M
Net Change in Cash i-60.4M218.1M57.1M-135.9M173.1M

Cash Flow Trend

Kerala Ayurveda Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 617.16
Price to Book 58.76
Price to Sales 4.46
PEG Ratio 1.28

Profitability Ratios

Profit Margin -9.83%
Operating Margin 9.54%
Return on Equity -114.03%
Return on Assets -11.42%

Financial Health

Current Ratio 0.46
Debt to Equity 548.18
Beta 0.08

Per Share Data

EPS (TTM) ₹-11.25
Book Value per Share ₹8.36
Revenue per Share ₹113.42

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
keralayur5.9B617.1658.76-114.03%-9.83%548.18
Sun Pharmaceutical 3.9T37.745.4315.08%19.29%3.26
Divi's Laboratories 1.6T70.8710.9114.64%23.89%0.03
Sun Pharma Advanced 47.8B-13.92-21.95157.88%-53.22%-1.24
Aarti Drugs 43.0B22.813.1412.28%7.80%44.92
Sequent Scientific 44.3B153.956.282.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.